Embed Size (px)
Citation preview
1
Audrey’s Life Science Meeting Picks for May 1, 2016 – August 2016
Complimentary Service of AudreysNetwork.com
May 1, 2016
*****************************************************************
BioDesign at Stanford, Monday Evening, May 2, 2016
Event: “Stanford Biodesign, 15 Years of Innovation: Past, Present and Future
Perspectives”
Impressive list of speakers on panel
Date and Time: Monday, May 2, 2016, 5:30 pm,5:30 PM program, 6:30 PM reception
Location: Schwab Residential Center Vidalakis Dining Room, 680 Serra Street.
Stanford, CA 94305
Please RSVP. Questions? Contact [email protected]
Event Description
Please join us for an evening of dialog and hospitality celebrating 15 years of
Stanford Biodesign. Interviews with program leadership and alumni. Exciting
announcements to be made! Cocktail reception and festivities to follow.
***************************************************
Bio2Device Group, Tuesday Morning, May 3, 2016
Topic: “Launching telemedicine devices abroad: a case study in CV”
Speakers: Srikanth Jadcherla, Professor and Chairman of the Board, Global Technology
University, Chairman of the Board, Piitech Inc. and Dr. Rich Goldman, Chief Marketing
Officer, PiiTech
Date and Time: Tuesday, May 3, 2016, 8:30 am
Location: Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
There is no fee or registration required for morning meetings.
Topic Description
In India, the telemedicine market is experiencing exponential growth – driven by the fact
that 80% of the doctors are in urban areas and 70% of the population is rural. A relaxed
regulatory regime, micropayment structures, widespread availability of cellular devices and
increased awareness in the population are leading to rapid proliferation. Leading hospitals
have already begun telemedicine efforts and 20+ telemedicine smartphone based players
are gearing up. We expect over a million telemedicine operators (para medical personnel) to
be operating by 2020.
Specifically, cardiovascular disease is at epidemic levels in India, with 1 in 4 adults at risk;
the average age of heart attacks is now around 40. iMedrix, a Silicon Valley Based startup
is entering the market with a lightweight, rugged, mobile ECG/EKG device for field screening
and triaging. iMedrix went from seed funding to post-trial revenue generation in less than 9
months. iMedrix devices are on a fast path to clinical workflow integration setting a
precedent for rapid trials and telemedicine subscription models. In a short period, 1000s of
readings have been taken and we anticipate that to grow to over a million later this year.
2
As we have traversed this path at rocket speed, we have had many valuable learnings. The
speakers will present an overview of the Indian telemedicine market and share their insights
and experiences.
Speaker Bios Srikanth Jadcherla is a well-known Low Power Guru, technologist, educator, entrepreneur, investor and green evangelist. He is on a mission to make education and healthcare accessible and affordable anywhere. Srikanth’s primary area of technical work is in low power chips and systems. He is a veteran of low power designs and pioneer of many energy efficiency techniques and principles. Jadcherla received an Intel Achievement Award, Intel’s highest honour, for his work on low power and is the author of 13 patents/applications. He was the founder of Archpro, where he created the theory of Voltage Aware Boolean analysis for low power ICs and systems. Archpro was acquired by Synopsys in 2007. His current area of research is on 3
rd generation low power designs, IOT protocols, IOT verification,
mobile big data, IOT medical access and smart grid energy control algorithms. He is a prolific speaker on wide ranging topics such as System/SOC verification, energy management, energy policy and educational reforms. Prof. Jadcherla holds a bachelor’s degree in electrical engineering from IIT-Madras in India, and a master’s degree in computer science and engineering from the University of California, Santa Barbara. He is a Charter member of the TiE and is actively involved in angel investments, incubations and mentoring activities.
Rich Goldman.Chancellor of Global University of Engineering and Chief Marketing Officer,
PiiTech
Rich Goldman is Chancellor of Global University of Engineering and a consultant to the
semiconductor industry with more than 25 years of global experience developing strategic
alliances, technology standards and marketing programs that align with company strategy
and drive results. In 1986, Rich established Texas Instruments' ASIC operation in
Bangalore, India. In 1992, he founded Russian-American Software, amongst the first US-
Russia collaborations in software. While serving as a vice president at Synopsys, Inc., and
CEO of Synopsys Armenia, Rich helped develop a number of programs to foster high tech
education worldwide, garnering honors such as guest Professor at the Chinese Academy of
Science, and Honorary Professor at the Moscow Institute of Electronic Technologies. With
Michael S. Malone and the President of Armenia, Rich established the Armenia’s Presidential
Award for Contribution to Humanity Through IT, bringing to Armenia Steve Wozniak, Craig
Barrett, and Federico Faggin.
Rich has presented at TEDx, and coauthored the book “STARMUS” with Neil Armstrong,
Buzz Aldrin, Alexi Leonov, Kip Thorne, Richard Stzostak, George Smoot, Steven Hawking,
Brian May, and others. Rich earned a BSCS from Syracuse University, an MBA and MS
Engineering Management from The University of Dallas, and an honorary Doctorate from
The State Engineering University of Armenia.
****************************************************************
BMES Industry Group: San Francisco/Bay Area, Tuesday Evening, May 3, 2016
Topic: “What Should Healthcare Innovation in Emerging Markets Be Focused On: New
Product Ideas or Market Development?”
Speaker: Dr. Anurag Mairal, MedTech Innovator, Academic, Entrepreneur
Date and Time: May 3, 2016, 6:00 pm
Schedule:
3
● 6:00pm Brief Charter Meeting
● 6:30pm Light Dinner & Networking
● 7:00pm Dr. Mairal’s Presentation
Location: Triple Ring Technologies, 39655 Eureka Dr, Newark, CA 94560
Reduced Introductory Rate:
● $10.00 Advanced registration (by May 1, 2016)
● $15.00 At door, if space available (cash or check payment only)
All are welcome:
Reserve your spot today. Space is limited.
http://www.bmes.org/4DCGI/cms/review.html?Action=CMS_Document&DocID=257&MenuK
ey=none
Group Description:
What is BMES? The Biomedical Engineering Society (BMES) is the professional society for
biomedical engineering and bioengineering. Founded in early 1968, the Society now boasts
nearly 7,000 members and is growing, rapidly.
Our Group's Mission is as follows:
To create a biomedical industry community in the San Francisco Bay Area that provides:
* Mentoring for students, young professionals and newcomers to industry,
* Networking for collaboration and talent recruitment,
* Continuing Education (e.g., technology, clinical, professional development, industry
trends, funding, regulatory, communication, interviewing),
* Promotion of the Industry in the region.
More Information: For more information about joining our Industry Networking Group,
contact Denise Forkey, Cofounder and President, (650) 799-9258 or
Speaker Bio:
Dr. Anurag Mairal is a Consulting Associate Professor of Medicine and the Director, Global
Exchange Program at Stanford Biodesign, Stanford University. In these roles, he leads
initiatives focused on applying the biodesign process to resource-constrained settings
globally. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a
SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus
on medtech, pharmaceutical, and digital health industry. Recently, he took a two-year
sabbatical to take a senior leadership role at PATH, a major global health nonprofit based in
Seattle. In this role, he oversaw research and development, commercialization,
and implementation of technologies in PATH's medical devices, diagnostics, and digital
health divisions. Previously, he held several positions at Johnson & Johnson, including
Business Development Director and Product Director for structural heart, cardiology, and
peripheral vascular products at Cordis. Dr. Mairal has a PhD in chemical engineering from
the University of Colorado at Boulder and an MBA from the University of California at
Berkeley. He also holds an MS in chemical engineering from the Indian Institution of
Technology in Mumbai and a BS in chemical engineering from National Institute
of Technology, Raipur. He has more than 30 publications and seven issued patents.
********************************************************************
Stanford Law Program in Law, Science and Technology, Wednesday, May 4, 2016
Event: Stanford IP Law And The Biosciences Conference
Confirmed Speakers
o Victoria Brewster, Fisherbroyles, Llp
4
o Trevor Cook, Wilmerhale
o John Duffy, University Of Virginia School Of Law
o Rebecca Eisenberg, University Of Michigan Law School
o Deborah Fishman, Kaye Scholer
o Hon. Arthur Gajarsa, Formerly United States Court Of Appeals For The Federal
Circuit; Wilmerhale
o Robert Galvin, Wilmerhale
o Hon. Paul Singh Grewal, United States District Court For The Northern District Of
California
o Hon. Faith Hochberg, Formerly, United States District Court For The District Of New
Jersey
o Hon. Susan Illston, United States District Court For The Northern District Of
California
o William "Bill" Lee, Wilmerhale
o Mark Lemley, Durie Tangri Llp; Stanford Law School
o Michael Lisi, Ariosa Diagnostics
o Lisa Larrimore Ouellette, Stanford Law School
o Arti Rai, Duke University School Of Law
o Hon. James Selna, United States District Court For The Central District Of California
o Hon. Gregory Sleet, United States District Court For The District Of Delaware
o Laura Storto, Genentech
o John "Jay" Thomas, Georgetown Law
Date and Time: Wednesday, May 4th, 2016, 8:30 am – 5:15 pm
Location: Stanford University, Paul Brest Hall, 555 Salvatierra Walk, Stanford, CA 94305
This event is open and free to the public, but registration is required. For more information,
to view the agenda, and to register, Register At
Http://Web.Stanford.Edu/Dept/Law/Forms/2016iplaw.Fb
For questions and information:
E:mail: [email protected]
Phone: 650 723-5905
Event Description
Join Us On May 4, 2016 From 8:30 A.M. To 5:15 P.M For The Stanford Ip Law And The
Biosciences Conference, An Informative Discussion With Leading Experts From Academia,
Industry And The Judiciary On The Latest Developments In Intellectual Property Law And
The Biosciences. Judges, Top Legal Scholars And Experienced Practitioners From Across The
Country Will Examine Some Of The Key Legal And Policy Issues Raised By The Biosciences
Industry.
Panels
o Patent Litigation In The Biosciences Circa 2016: A View From The Bench
o Biosimilars
o Patentable Subject Matter In A Post-Myriad And Post-Alice World
o Trade Secrecy, Data Exclusivity, Regulation And Other Alternatives To Patent
Protection In The Biotech Space
o Luncheon Keynote
************************************************
qb3, Thursday MidDay, May 5, 2016
Register now for the QB3 Spring 2016 NSF SBIR Bootcamp
UCSF Mission Bay
5
Two one-hour classes. Location: Genentech Hall N-114, UCSF Mission Bay
First session: Thursday, May 5
Second session: Thursday, June 9
Please note that this workshop will exclusively focus on the specifics of the NSF
application and will not cover the basic information covered in our longer course. For
this reason, we recommend that you sign up for this session if you have previously
attended the QB3 NIH SBIR workshop or have a basic understanding of the SBIR
process.
Our NSF SBIR/STTR workshop will address specific differences between the NSF and
NIH applications to successfully file a well-written SBIR/STTR grant application for
the June 16 NSF SBIR deadline (June 20 for STTRs). The course culminates in a
submission clinic that will ensure your application is correctly filed.
One or more team members from the company should be prepared to attend every
session.
Remember to bring your laptop; these will be working sessions.
Course includes
One 1-hour working session, plus one 1-hour filing clinic
Pre-submission review of specific aims by our course instructors
Session 1 will cover the application process, including registration
Session 2 will cover the upload and submission process
Schedule
Dates Time Location
5/5 (Thurs) 1:00-2:00 PM Room N-114, Genentech Hall
6/9(Thurs) 1:00-2:00 PM Room N-114, Genentech Hall
Instructor: Shauna Farr-Jones, PhD, UCSF/QB3 grant writer
Standard rate for the entire workshop: $150 per company
Discounted rate for UC affiliates, QB3 Startup in a Box members, QB3 Incubator
members, and QB3/CLSA Accelerator members: $50 for entire course per company
Teams registered for the Spring 2016 QB3 NIH SBIR workshop: $0
Have questions about QB3 Spring 2016 NSF SBIR Bootcamp? Contact QB3
**************************************************************
Bio-X, Saturday, May 7, 2016
In vitro Vascularized Constructs as Models of Metastatic Cancer
Date and Time: Saturday, May 7, 2016, noon
Location:
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
SMALL LUNCH SERVED AT 12:00��; LECTURES BEGIN AT12:15��
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
Pre-Seminar Speaker: Alexander Dunn, Department of Chemical Engineering
May 19, 2016
Seminar Speaker: Roger Kamm, MIT
In vitro Vascularized Constructs as Models of Metastatic Cancer
*****************************
CABS, Saturday, May 7, 2017
Event: 2016 BioPacific Conference
Date and Time: Saturday, May 7, 2016, 8 AM- 9 PM
Location: San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402
6
Registration:
Refreshments, lunch and dinner are included for all registrants
CABS Member Early Bird Registration
(before 04/15/16)
Regular Registration
(04/16/16 - 04/30/16)
Late Registration
(after 04/30/16)*
General $65 $100 $200
Student/Postdoc** $50 $80 $160
Non-Member Early Bird Registration
(before 04/15/16)
Regular Registration
(04/16/16 - 04/30/16)
Late Registration
(after 04/30/16)*
General $125 $160 $260
Student/Postdoc** $110 $140 $220
*No guarantee on lunch and dinner
Register at
http://www.cabsweb.org/events/2143408/Registration+is+Open%3A+2016+BioPacific+Co
nference/
Description:
Our meeting will showcase:
Winner of 2016 CABS K. Fong Award in Life Sciences
Most promising areas in life sciences
Opportunities and challenges for developing biopharmaceuticals in China
Cross border financing and entrepreneurship
Success stories of entrepreneurs and emerging companies
Confirmed Speakers and Panelists include:
Hari Kumar, CEO, Adheron Therapeutics
Piers Whitehead, EVP & CBO, PaxVax
Mark Selby, Ph.D., Senior Director of Immuno-Oncology, Bristol- Myers Squibb
Edward F. Chang, M.D., Associate Professor of Neurological Surgery and Physiology,
Co-Director, Center for Neural Engineering and Prostheses at UC Berkeley and UCSF,
New York Stem Cell Foundation- Robertson Investigator University of California,
San Francisco
Lei Stanley Qi, Ph.D., Assistant Professor, Department of Bioengineering and of
Chemical and Systems Biology, faculty fellow in the interdisciplinary Institute for
Chemistry, Engineering, and Medicine for Human Health
Shawn Qian, Ph.D., CEO, Neupharma
Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen
Xian-Ping Lu, Ph.D., Co-Founder, CEO and CSO, Chipscreen Biosciences
Dan Zhang, M.D., Ph.D., CEO, Fountain Medical Development
Yongmei "Alexis" Ji, Ph.D., MBA, Principal, WuXi Ventures
James Zhao, M.D., M.S., MBA, Founding Partner, LYFE Capital
Yuwen Liu, MBA, MS, Founding Partner, BoHe Angel Fund
Min Cui, Ph.D., Founding Partner and Managing Director, Decheng Capital
This highly anticipated full day event is expected to attract over 600 life science
professionals from San Francisco Bay Area as well as Pacific Rim countries.
Contact for Sponsorship/Exhibition Opportunities: [email protected]
*************************************************************************
Bio2Device Group, Tuesday Evening, May 10, 2016
Topic: Is discovery research a luxury or a necessity in biotech?
Speaker: Austin Gurney, Ph.D, CSO, Senior VP, Molecular and Cellular Biology, Oncomed
7
Date and Time: Tuesday, May 10, 2016, 6:00-9:00 pm
Location: Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Payment Options
We use PAYPAL to process your online payment. Print and bring a copy of your online
receipt with you. If space permits, walk-ins are welcomed; please be prepared to pay $20
cash or check. There is no refund, exchange, or transfer. Thank you for your cooperation.
To register now, select the appropriate registration level and your meal preference from the
pull-down menus below and enter the name and email of the attendee. Then click on the
"Pay Now" button to reach the PayPal payment page. Each attendee must be registered
separately. Please register a non-member by logging out first.
Make sure you enter the attendee's meal choice, name, and email address.
Register at www.Bio2DeviceGroup.org starting the weekend of April 23-24, 2016
http://goo.gl/LyEJXT
Topic Description
Building a biotech company is challenging for a multitude of reasons. Among the greatest
challenges is the difficulty financing a company though the long journey towards the
creation of new medicine. Research, particularly basic discovery research is often perceived
as a cost and burden which needs to minimized in order to marshal resources towards the
advancement of a lead clinical program. However, it can be argued that creating “the next
Genentech” will remain metaphor rather than reality without investment in research by new
biotechs. I will share our experiences and observations building a biotech anchored on a
model of ongoing and substantial investment in basic discovery research. Among our
surprising observations: rather than being a cost, research has funded the company!
Speaker Bio
Austin Gurney joined OncoMed Pharmaceuticals at its founding as Vice President of
Molecular and Cellular Biology. Prior to OncoMed, Dr. Gurney worked at Genentech where
his research contributed to the discovery of numerous growth factors and cytokines. He has
authored or co-authored more than 60 papers and is listed as an inventor on over 600
patents related to therapeutic applications in immunology and cancer. Dr. Gurney has two
decades of experience in biotechnology and in the development of novel therapeutics.
Dr. Gurney conducted his Ph.D. work at Case Western Reserve University. He completed
post doctoral studies with Dr. Bryan Williams at the Cleveland Clinic, and at Genentech with
Dr. David Goeddel.
*************************************************************************
sfAWIS, Tuesday Evening, May 10, 2016
Topic: "The Conflict Shift: from Conflict to Cooperation"
Speaker: Susan Bernstein, MBA, PhD, Executive Coach and Leadership Training
Date and Time: Tuesday, May 10, 2016, 6:30 pm
6:30-7:00 pm Dinner/Networking
7:00-8:00 pm Presentation by Dr. Susan Bernstein
8:00-8:30 pm Q&A and Networking
Location: Women's Building, Audre Lorde Room, 2nd floor, 3543 18th St., San Francisco
Near 16th Street Mission BART station.
8
This event is open to all scientists and non-scientists. You do not need to be an AWIS
member to attend.
Light dinner provided.
Cost:
Online registration in advance by May 9: Free for sfAWIS members/students; $10 for non-
members. At the door: $5 for sfAWIS members/students; $15 for non-members. Register at
http://www.eventbrite.com/e/the-conflict-shift-from-conflict-to-cooperation-tickets-
23016989435?ref=ebtn
Topic Description
Research shows that an aversion to conflict is one of the common roadblocks in the
workplace that holds women leaders back from moving to the next level. Whether in our
professional or personal lives, we can get entangled in unnecessary conflict drama. We
waste our precious energy battling people we imagine as foes, defending ourselves from
apparent enemies, and rescuing others from perceived tyrants. These are dynamics that
we’ve learned to play out; yet when we become conscious of them, we have the ability to
choose new roles that allow us to be more genuinely powerful and productive.
Dr. Susan Bernstein, MBA PhD, will lead a fun, dynamic interactive workshop, where you
will will:
Learn about the three key roles we unconsciously play that create unnecessary
drama, and identify how these roles have impacted power dynamics throughout our
lives
Experiment with each of the three roles in conflict dramas, to get an inner sense of
the roles, needs, and unexpressed power
Discover an approach to conflict that empowers everyone into collaborative "power
with," rather than "power over"
Define strategies for transforming dynamics in your own environment
Speaker Bio
Susan Bernstein, MBA PhD has been an executive + career coach since 2001. Her specialty
is helping high-achieving mid- to senior-level professionals who seek to gain greater
meaning and satisfaction from their work. Susan spent the first fifteen years of her career in
high-stress, high-stakes leadership roles at Franklin-Covey, Intel, and Accenture. So she
knows the pressures her clients face to excel in demanding roles. She’s also been wildly
curious about how people get past issues like perfectionism, procrastination, and conflict to
actually make big shift in their careers. She earned her MBA at UC Berkeley’s Haas School
of Business and a PhD in Mind/Body Psychology from the Santa Barbara Graduate Institute.
Learn more about Susan at www.SensationalShift.com
*********************************************************************
RAPS, Wednesday Afternoon, May 11, 2016
Topic: “Navigating US Market Access Landscape for Optimal Regulatory and Business
Strategy”
Speaker: Speaker:
Jane Horvath, MHSA, market access lead, 3D Communiations
Date and Time: Wednesday, May 11, 2016, 5:30 - 8:00 pm
Wednesday, 11 May 2016
5:30 pm Registration Check-in, Light Dinner
6:00 pm Welcome and Opening Comments
6:15 pm Presentation
9
7:15 pm Open Discussion/ Q&Q Session
7:45 pm Program Concludes
Location: Johnson & Johnson, 6500 Paseo Padre Pkwy, Fremont CA 94555
Prior to 4 May:
RAPS Members: $25
Nonmembers: $35
On or After 4 May:
RAPS Members: $35
Nonmembers: $45
More Information >
Register at https://raps.org/EventDetails.aspx?ProductId=93225532
Topic Description
Meet your regulatory colleagues from across the San Francisco Bay area during an expert
presentation on “Navigating US Market Access landscape for Optimal Regulatory and
Business Strategy,” with Jane Horvath, MHSA.
Topics to be covered include:
• A review of basic of Medicare coverage and reimbursement policies and practices
• An understanding of key changes in the US commercial healthcare market that affect
access\
• How to address more vocal and new stakeholders influencing market access
• Best practices for how to enter the US market with better value communications by
starting early in the development process
This meeting is sponsored by the RAPS San Francisco Chapter and is intended to promote
knowledge advancement and facilitate networking among local regulatory professionals. A
light meal will be available and attendees may claim two (2) RAC recertification credits.
A valid photo identification will be required to enter the premises. Participants will not be
able to gain access without a Photo ID.
Speaker Bio
Jane Horvath, MHSA, leads 3D's Market Access and Value Communications team. Jane
brings nearly 25 years of experience in health policy and reimbursement issues to 3D
clients. As Executive Director of Health Policy and Reimbursement at Merck for a decade,
she identified the business implications of state and federal policy developments including
the Medicare prescription drug program, Medicaid, health information technology, Big Data
access and methods, 340B, and reformed commercial markets. Prior to Merck, Jane was
Deputy Director of the Robert Wood Johnson Foundation project at Johns Hopkins University
School of Public Health, conducting research and devising policy on care management and
financing for people with chronic conditions. Jane also held a series of high profile
government positions. This included work as Deputy Assistant Secretary for Legislation in
the US Department of Health and Human Services, responsible for legislative policy for all
health-related areas, including Medicare, Medicaid, and prescription drug pricing. Recently
Jane was Vice President at Breakaway Policy Strategies focused on biopharma issues and
clients. Jane earned a Masters of Health Services Administration from the George
Washington University.
******************************************************************
WIB, Wednesday Evening, May 11, 2016
Event: “Speed Networking at Molecular Devices”
Date and Time: Wednesday, May 11, 2016, 5:30 p.m. – 7:30 p.m. PST
5:30 p.m. – 6:00 p.m. Check-In and Reception
10
6:00 p.m. – 6:15 p.m. WIB Welcome and Event Introduction
6:15 p.m. – 7:15 p.m. Speed Networking
7:15 p.m. – 7:30 p.m. Wrap-Up
Location: Molecular Devices, 1311 Orleans Drive, Sunnyvale, CA 94089
Pricing Information
Members: $20
Non-Members: $35
Register at http://www.womeninbio.org/eventdetails.aspx?EventId=28671
Walk-Ins Accepted?
Walk-ins are not accepted – be sure to register early!
Registration Deadline
May 10, 2016
Event Description
Join members of the Bay Area biology community at WIB’s speed networking event! This is
a great opportunity to meet other women working in biotech, and to learn about Women In
Bio. We’ll start with an informal reception with refreshments and plenty of time for
conversation, followed by a speed networking event with five-minute one-on-one
interactions. Special thanks to Molecular Devices for hosting!
***************************************************************
HBA San Francisco, Thursday Morning, May 12, 2016
Event: “2016 Woman of Year Event – West”
Date and Time: Thursday, May 12, 2016, 8:00 – 11:00 am
8:00 - 8:30 AM Check in and networking
8:30 - 8:40 AM Welcome and opening remarks
8:40 - 9:25 AM Leadership panel
9:25 - 11:15 AM Live broadcast into WOTY, awards and networking
10:15- 11:00 AM Dress for success, raffle, networking and closing remarks
Event location
Genentech
611 Gateway Blvd., Building 82
South San Francisco, CA 94080
650-225-1000
Details and registration at
https://my.hbanet.org/MyHBA/EventDetails.aspx?MeetingID=C6A15543-C9DC-E511-A054-
0050569C00A7
Event Description
HBA celebrates Jennifer Cook, head of pharma for Europe region at Roche, as our 2016
Woman of the Year (WOTY). In addition, we will celebrate the 2016 Honorable Mentor
Jacopo Leonardi, executive vice president and president, Immunology at Baxalta
Incorporated, and nearly 100 Rising Stars and Luminaries.
At Genentech, we will participate in WOTY via a live satellite over breakfast. In addition to
Rate
Member: $25
Non-member: $35
Student: $20
Genetech employee: $15
11
the live feed, we will hear from a variety of senior leaders from Genentech, Deloitte and
other San Francisco companies and also provide the opportunity for networking throughout
the event.
******************************************************************
EPPIC and Genentech, Friday MidDay, May 13, 2016
Event: Global Perspectives for Payer Evidence and Impact on Pricing and Access
Speakers: Brian O’Shea and Jeff Hille
Date and Time: Friday, May 13, 2016 12:00 -1:00 PM
Location: Genentech Campus - Building 42-1C, 455 E. Grand Avenue, South San Francisco,
CA 94080
Lunch will be provided from 11:30 onwards
Free Registration ends on Friday, May 09, 2016
Register FREE for this event at: https://www.123signup.com/register?id=ngrjv
Topic Description
The global payer environment in the biopharmaceutical space is getting increasingly
complex at a time when biopharmaceutical innovation is leading to unprecedented advances
in treatment of difficult diseases. Regulators are increasingly more open to approving
breakthrough medications, at a time when payers are struggling to manage increasingly
tight budgets and growing demand for healthcare services. Brian O’Shea and Jeff Hille, from
The Global Pricing and Market Access Group at Roche will discuss these challenges at a
global level, and will specifically describe how these challenges are addressed in
key individual countries.
Speaker Bios
Brian O’Shea is Director in the Global Pricing and Market Access group at Genentech/Roche.
He leads a team of 6 international payer strategy leaders responsible for pricing and global
market access for Alectinib, Zelboraf, Erivedge, Cotellic, Tecentriq and market preparation
for several early molecules. In his 8+ years at Genentech/Roche, he has had a variety of
leadership experiences and roles, including starting the Reimbursement Strategy Team in
Managed Care and Customer Opetarions, International Payer Strategy Leader on multiple
molecules including Zelboraf and Erivedge, and Channel and Access Solutions Marketing
team lead. He has over 25 years of industry experience and has previously worked at GSK,
Astrazeneca, and Merck.
Jeff Hille is Senior International Payer Strategy leader: Oncology Pipeline in the Global
Pricing and Market Access group at Genentech/Roche. He joined the company over 8 years
ago and held leadership positions in the Managed Care and Customer Operations, and
Health Economics and Outcomes Research groups, and as the International Payer Strategy
Leader on Perjeta. Jeff has over 14 years in of industry experience and has previously
worked at Eli Lilly.
About Genentech and EPPIC
Genentech, a pioneer in Biotechnology, is well known for its investment in innovation and
the principles of partnering, mentoring and networking within its organization as well as the
wider life sciences community.
EPPIC GLOBAL has enjoyed partner events and sponsorship support from Genentech for
over a decade. In 2016, EPPIC is proud to announce that Genentech was one of the
Platinum Sponsors to the annual flagship conference – EPPICon 2016. Several leaders from
Genentech were at the event and many symbiotic interactions have already begun.
12
Come join EPPIC today!
EPPIC strives to bring its members partnering and enriching events that synergize the
values and principles of the organization.
**************************************************************
Stanford Medicine, Saturday, May 14, 2016
Topic: “Health Matters 2016”
Date and Time: Saturday, May 14, 9:00 a.m. – 2:00 p.m.
Location: Li Ka Shing Center for Learning and Knowledge, 291 Campus Drive, Stanford
Registration opens on April 1.
Details at http://healthmatters.stanford.edu/
Podcasts and videos of the 2015 event are also listed.
Topic Description
health matters is a free community event hosted by Stanford Medicine that explores the
latest advancements in medicine and the health topics that matter most to you and your
family.
****************************************************************
NCC-AWIS, Tuesday Evening, May 17, 2016
Event: Annual Awards and Recognition Banquet
Keynote Address Speaker: Susanne Lindgren, PhD, professor at Cal State
University, Sacramento and was the 2015 Judith Pool Award recipient.
Date and Time: Tuesday, May 17th: 6:00pm - 9:30pm
Location: Dominic's at Oyster Point: South San Francisco
Advance RSVP required
Event Description
The AWIS Northern California Chapters' Annual Awards & Recognition Banquet is
approaching. We cordially invite you to join us for a lovely dinner party and inspiring
evening.This annual event, hosted by AWIS-NCC brings together four chapters to celebrate
three distinguished women scientists being recognized for mentorship. Early bird ticket
special available through May 9th.
RSVP for the ceremony today!
Fees and registration at http://www.brownpapertickets.com/event/2533796
Join us for our annual celebration of women in science:
Mingle, enjoy wine and appetizers, and then stay for a lovely buffet dinner
and ceremony
Reconnect with friends and make new ones from around the bay
Be inspired by personal stories of excellence in science and mentoring
Leilani Miller, PhD, of Santa Clara University will receive the 2016 Judith Pool Award.
Wendy Fantl, PhD, of Stanford University will receive the 2016 Ellen Weaver Award.
Tracy Lin, RPh, of Johnson & Johnson will receive the 2016 Sherrie Wilkins Award.
Reserve your banquet ticket now. Registration is $40 through May 9th, and $50 May 10-16.
No onsite registration.
**************************************************************
BioPharmaPM, Wednesday, May 18, 2016
13
Event: “2016 BioPharmaPM annual conference: "Strategic and Business Management,
Leadership, & Technical Project Management: Leveraging the PMI Talent Triangle in
BioPharma"”
Date: Wednesday, May 18, 2016.
Details and registration at https://www.biopharmapm.org/conference
We are also taking advantage of technology and holding the conference at two locations via
videoconference to enable and encourage greater participation. Our sponsors for the event,
Genentech and Pfizer, have graciously offered to host the event at their facilities in South
San Francisco and La Jolla, California, respectively. We will have speakers and networking at
each site, so if you are local to these facilities, or able to travel, please plan on attending.
The registration fee is $299 for the one-day conference and for 2016, we are including an
annual membership to the organization in the cost. Registration is a two-step process on
our website: 1) Pay for the conference and 2) Complete the registration. Following
payment, please "Register for the Conference" to register your name so you receive all
updates as the conference date approaches.
The conference will be held on May 18th at two locations via videoconference. Our sponsors
for the event, Genentech and Pfizer, have graciously offered to host the event at their
facilities in South San Francisco and La Jolla, California, respectively. We will have speakers
and networking at each site, so if you are local to these facilities, or able to travel, please
plan on attending. Given our sponsors' generosity, Genentech and Pfizer colleagues will be
eligible for a significant discount on the registration fee. If you are a colleague at a
sponsoring organization, please contact me directly at [email protected] on
how to access this discount.
Registration is limited to 100 participants per location, so register soon! We look forward to
seeing you at the conference!
*****************************************************************
EMBS, Wednesday Evening, May 18, 2016
Topic: “Digital Medicines Provide Physicians With Insights into Patient Medication-taking
Patterns and Physiologic Response, Enabling Efficient Therapy Optimization”
Speaker: Mark J. Zdeblick, Ph.D., Co-Founder, Chief Technology Officer, Proteus Digital
Health, Inc.
Date and Time: Wednesday, May 18, 2016, 7:30 PM
Location: Room M-114, Stanford University Medical School
Optional dinner location: Stanford Hospital cafeteria, 6:15 PM (no host, no reservations)
Topic Description
Proteus Digital Health is a company with an innovative solution for activating patients and
helping improve medication adherence. This novel digital Medicines as a Service (MaaS)
offering is called Discover. Discover utilizes sensor-enabled pills and small wearable patch
that unlocks comprehensive data about medication adherence and clinical effectiveness,
empowers more meaningful conversations between patients and caregivers, and delivers
actionable insights about entire healthcare populations. Discover and patient and physician
reaction will be described in detail. The talk will conclude with highlights from recently
announced (ACC, April 2016) cluster randomized trial that revealed that patients with
uncontrolled hypertension and diabetes who used Proteus Discover achieved statistically
14
significant reduction in blood pressure (BP) and low-density lipoprotein-cholesterol (LDL)
and were more likely to achieve their BP goal than usual care.
Speaker Bio
Prior to co-founding Proteus Digital Health, Mark Zdeblick served as the chief technology
officer for the optical switch group at K2 Optronics. Dr. Zdeblick is also founder, director and
past chief technical officer of Redwood Microsystems, developer of the world’s highest
performance microfabricated valves and electro-fluidic integrated circuits. While working in
Professor Calvin Quate’s engineering group at Stanford, Dr. Zdeblick invented the
microfabricated cantilever beam with an atomically sharp tip that enabled atomic force
microscopy. He holds a B.S. in civil engineering (Tau Beta Pi, Phi Eta Sigma) and a B.A. in
architecture, both from the University of Illinois, and an M.S. in aeronautics and
astronautics and Ph.D. in electrical engineering from Stanford University. He is named as an
inventor on over 300 issued patents and is an advisor and/or lecturer to engineering
programs at Rice University, Stanford University, and UC San Diego.
*****************************************************************
GGPF Dinner, Wednesday Evening, May 18, 2016 Lecture: "Polymer and Mixed-Matrix Membranes for Gas Separations" Speaker: Dr. Zachary P. Smith, Department of Chemistry,University of California, Berkeley Date and Time: Wednesday, May 18 6:00 PM social hour 7:00 PM dinner 8:00 PM presentation Location: Michael's at Shoreline, 2960 N Shoreline Blvd., Mountain View Cost: Employed/postdocs: $30 early registration, $35 regular registration; Unemployed/retired/students: $15 early registration, $20 regular registration Free if you attend just the lectures at 8:00 PM (but please let us know for headcount) After deadline: Registration not guaranteed, so contact us Late fee applies if space available -- $40 regular/employed, $25 unemployed/student/retired Deadlines for registration: End of discounted advance registration 11:59PM, Friday, May 13 End of regular (full-price) registration 5PM Tuesday, May 17 Register at www.GGPF.org<http://www.GGPF.org> (PayPal is enabled if desired) Because we must pay the restaurant for the ordered meal, we must ask no-shows to pay for their reservation. However, penalty-free cancellations are allowed up until the deadline for reservations (Tuesday, May 17, 5:00 PM). PLEASE NOTE: We accept cash or checks at the door, but are unable to accept payment by credit card at the event. You may pay at the door. Checks may be made to "GGPF" Discounted advance registration ends 11:59PM, Friday, May 13 Final full-price registration ends 5PM, Tuesday, May 17 Please register on the web page Or, if necessary, contact: Len Radzilowski 650-361-3264 [email protected]<mailto:[email protected]> Topic Description
15
In the U.S. today, there are over 40,000 distillation columns performing more than 200 separations, which account for 49% of the total separation energy consumption in industry. Other energy intensive and environmentally harmful processes such as amine absorption are also used on a large scale, so a need exists to find alternative separation technologies. Of particular promise are membrane-based separations, which, unlike distillation, circumvent significant energy requirements for phase changes, and, unlike absorption, operate in continuous flow, thereby avoiding regeneration steps. Here, a broad overview on membrane-based gas separations will be presented, with an emphasis on current and emerging applications and materials. Next, three strategies will be presented on methods for designing new materials for efficient and productive separations. From a polymer perspective, two approaches will be presented, one on manipulating polymer morphology to control diffusion rates, and the other on using perfluorinated polymers to manipulate polymer-penetrant interactions. Finally, an alternative strategy will be presented, whereby highly selective inorganic particles are dispersed into a polymer matrix to improve transport performance in a platform of materials known as mixed-matrix membranes. Speaker Bio Zachary P. Smith is currently a postdoctoral scholar in the Department of Chemistry at the University of California, Berkeley. He earned his bachelor's degree in Chemical Engineering from the Penn State Schreyer Honors College, conducting research with Prof. Hank Foley on porous carbon-based materials for applications in oxygen enrichment. Zach completed his graduate training in Chemical Engineering under the guidance of Profs. Benny Freeman and Don Paul at the University of Texas at Austin, developing structure/property relationships for gas diffusion and sorption in polyimides, perfluoropolymers, and related materials. His postdoctoral training, under the guidance of Prof. Jeffrey Long, focuses on designing coordination solids (i.e., metal-organic frameworks) for selective adsorption-based separations. Zach has co-authored over 20 peer-reviewed publications and has been recognized with several awards including the Department of Energy Office of Science Graduate Fellowship and the ACS Excellence in Graduate Polymer Research Award. He was also selected as a U.S. delegate to the Lindau Nobel Laureate Meeting on Chemistry in 2013.
***************************************************************
JLABS, Thursday, May 19, 2016
Event: “WORKSHOP 3 | Lessons Learned: The IPO process from battle tested
Veterans”
Speakers:
Linda Bain | Chief Financial Officer, Codiak BioSciences read bio»
Isaac Ciechanover | President & CEO, Atara Biotherapeutics read bio»
[moderator] Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte &
Touche LLP
Date and Time: Thursday, May 19, 2016, 8:15 am
Agenda:
8:15 AM | Registration Opens, Breakfast and Networking
9:00 AM | Panel and Q&A
10:30 AM | Closing remarks and networking
11:00 AM | Program Close
Location: JLABS @ SSF, 329 Oyster Point Blvd - 3rd Floor, South San Francisco, CA
Day 3 Fees: $20 | General Public: $35 | At the door
Register at http://www.eventbrite.com/e/how-to-ipo-series-tickets-
20106147027?aff=blast#Day3
Event Description
There is nothing like experience! The final event in our 3 part IPO series with Deloitte
& Touche, LLP brings in two high profile C-level executives. They have gone through
the IPO experience and as IPO journey's go, their paths were different.
This breakfast event will take a look at two companies that recently went through
16
successful IPO's. The company leaders will share their insights from firsthand
experience on issues ranging from preparation to execution.
Topics include:
Hiring the right professional team
Managing the Board
The roadshow
Pricing, timing and market conditions
The surprises, pitfalls and lessons learned
With plenty of time for Q&A
Join us for an insider's look at the IPO!
Speakers' Biographies:
Linda Bain | Chief Financial Officer, Codiak BioSciences
Linda Bain joined Codiak from Avalanche Biotechnologies where, as chief financial
officer, she led a successful IPO and follow-on financing. She previously served as
vice president of finance, business operations and treasurer at Bluebird Bio. Ms. Bain
has held senior roles at Genzyme Corporation, including vice president of finance,
global manufacturing and operations and vice president of finance of Genzyme
Genetics. Earlier in her career, she served in senior finance roles at Fidelity
Investments and AstraZeneca Pharmaceuticals and as an auditor at Deloitte &
Touche.
Isaac Ciechanover, M.D. | President & CEO, Atara Biotherapeutics
Dr. Isaac Ciechanover is a physician, investor and entrepreneur driven by a passion
to improve the practice of medicine. Motivated by the belief that the majority of
medical discoveries still lie ahead, he has dedicated the past 20 years to working
with entrepreneurs and life sciences organizations to advance medicine through
innovation and technology. He founded Atara Biotherapeutics in August 2012.
Previously, he was a partner in the life sciences practice at Kleiner Perkins Caufield &
Byers. Earlier as Celgene's Executive Director for Business Development, he
spearheaded the company's venture capital efforts and led licensing and M&A
activities with an aggregate value of more than $6.7 billion. Also at Celgene, he was
Global Project Leader for the company's first clinical-stage biologic therapy. Isaac has
also held business development and venture capital roles at Amylin Pharmaceuticals,
Pequot Ventures' healthcare practice and Pfizer. Intellectually curious (and
undeterred by student debt), Isaac holds a B.A. from Stanford University, an M.Phil.
in Epidemiology from Cambridge University, an M.D. from Weill Cornell Medical
College and an M.B.A. from Harvard Business School. For fun, he enjoys cycling,
scuba diving and building Lego with his two children. His all-time favorite albums are
Pink Floyd's "The Dark Side of the Moon," Radiohead's "OK Computer" and Ruggero
Leoncavallo's Italian opera, Pagliacci, with Herbet Von Karajan conducting.
Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
Angela has 20 years of experience serving both public and private companies with a
focus on the life sciences industry. She works with companies in all stages of growth,
from start-ups to SEC registrants. Her technical background includes complex
accounting issues such as revenue recognition, equity, derivatives, stock-based
compensation, and acquisitions. Angela has been involved in financing and M&A
transactions, including initial public offerings, offerings in leveraged buyouts, and
several secondary shares offerings. She has extensive international experience and is
a certified public accountant in the United States and the United Kingdom. Angela
17
also served as a CFO before returning to public accounting in 2003.
**********************************************************************
QB3, Thursday Mid Day, May 19, 2016
Topic: “How to Navigate US Immigration Law for Biotech Entrepreneurs”
Speakers: Norman Plotkin and Atessa Chehrazi, partners at the immigration law firm of
Jackson & Hertogs
Date and Time: Thursday, May 19, noon to 1:00 pm
Location: Room 160, Helen Diller Bldg. (1450 Third St.), UCSF Mission Bay
Fee: General Admission - $10
Register at http://www.eventbrite.com/e/qed-norman-plotkin-and-atessa-chehrazi-how-to-
navigate-us-immigration-law-for-biotech-entrepreneurs-tickets-
21686104723?mc_cid=1a27eae361&mc_eid=cb4c38a44a
Topic Description
Biotech companies want to hire talented employees with the right skills but many
candidates may need to be sponsored by the employer because they might not be US
citizens or permanent residents. What are the options for entrepreneurs starting up
businesses? How can a founder establish an immigration policy to attract and retain the best
and the brightest? What visa options are available and how best to navigate through US
immigration laws? Norman Plotkin and Atessa Chehrazi, partners at the immigration law
firm of Jackson & Hertogs, will explain how the most common visas such as H-1B, J-1, and
TN work and will discuss recent developments in immigration law including changes to the
F-1 STEM OPT work authorization.
What you'll learn
• How US immigration laws work and what the differences are between the H-1B, J-1,
O-1, and TN visas
• How to establish an internal immigration program or navigate an employer’s
immigration program
• The most recent developments in immigration law
Speaker Bios
Norman became a partner in February 2002. Throughout his career, Norman has
been active in AILA. Previously, he served as the editor of the Gold Book, a resource
for practicing immigration law in California, and as co-editor of the Western Region
Directory for the Immigration Practitioner. He was also liaison for the Northern
California AILA Chapter to both the California Service Center and the U.S.
Department of Labor. In addition, he was a member of the national AILA/California
Service Center liaison committee and previously served on the national
AILA/Department of Labor liaison committee. He has also lectured at seminars and
conferences including national AILA Conferences, the BIO International Convention,
the BIO Human Resources Conference and the HR Star Conference. Norman has
received high marks in all legal directories, including a listing in the Best Lawyers in
America. He is fluent in Spanish.
Atessa has been a partner at Jackson & Hertogs since April 2013 and an
associate/senior associate since July 2000. She was previously an associate at
Maggio & Kattar in Washington, D.C. from 1996 to 2000. She has held several
volunteer roles within the American Immigration Lawyers Association (AILA) during
her career. For AILA’s Northern California Chapter, she has served as Chair, Vice-
Chair, Treasurer, U.S. Citizenship & Immigration Service (USCIS) liaison, and
Customs & Border Protection (CBP) liaison. On a national level, Atessa served on
18
AILA’s USCIS Headquarters and Benefits, Administrative Appeals Office (AAO), and
Department of Labor (DOL) liaison committee. In addition, Atessa has served on
AILA’s Business Immigration Advocacy, Issues, and Due Process & Civil Liberties
committees, as well as several conference committees. She has served as a board
member of the Iranian American Bar Association Northern California chapter since
2009 and is incoming President of the chapter. She is a member of the Bar
Association of San Francisco, and the National Lawyers Guild. She has authored
several articles published in AILA Handbooks. Atessa has presented at national and
regional AILA conferences. Atessa has been highly reviewed in legal directories,
including selection as a Northern California “Super Lawyer” (2010-2012), and listing
in the International Who’s Who of Corporate Immigration Lawyers (2011-2015).
*************************************************************************
Clark Seminar, May 19, 2016
Event: In vitro Vascularized Constructs as Models of Metastatic Cancer
Date and Time: May 19, 2016, noon
Location: Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
Small Lunch Served At 12:00; Lectures Begin At12:15
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
********************************************************************
PBSS, Tuesday Afternoon, May 31, 2016 T
Event Type: Workshop Workshop: ”Pharmacology animal models in drug development:
fundamentals, applications and case studies related to oncology, metabolic diseases,
inflammation and immunology”
Speakers: Dirk Mendel (E-Scape Bio), Stephen Gould (Genentech), Rana Samadfam
(Charles River Laboratories), Peter Havel (UC Davis), Leon Hall (Mousera)
Date and Time: Tuesday, May 31, 2016, 12:30-17:00
Location: SF Bay Area: Foster City Crowne Plaza
Registration fee (US$): Regular: $125; For vendor-show reps: $25; For unemployed &
students: $20; For major-sponsor rep (incl lunch): $0; For others, details available upon
online login.
Registration: http://www.PBSS.org
Further Information:
Registration deadline: 5/27/2016 (it will close sooner if the seating cap is reached)
********************************************************************
South Bay HBA, Saturday, June 4, 2016
Event: South Bay Coffee Chat
Location: Shoreline Lake American Bistro - 3160 N Shoreline Blvd., Mountain View, CA
To RSVP or for more information, please contact Meggin Taylor or Mary Dosunmu
*************************************************************************
BIO International Conference, June 6 – 9, 2016
Dates: June 6 – 9, 2016
Location: Moscone Convention Center, North, South and West Halls
Fees: Convention Access - $1,200, Members and 1,450, Non Members before April 16;
$1,400, Members and $1,750 for nonmembers after April 16 (see other package pricing at
http://convention.bio.org/register/)
*****************************************************************
19
WIB, Monday Afternoon, June 6, 2016
Topic: Women in Bio Plenary Event at BIO Convention: “The Influential Paths of Great
Visionary Leaders”
Speakers include: Firelli Alonso, Senior Director, Biotherapeutics and Vaccines Outsourcing,
Pfizer; Lisa Cohen, Executive Director, Washington Global Health Alliance; Renee Compton
Ryan, Vice President, Venture Investments, Johnson & Johnson; Bahija Jallal, Executive Vice
President, AstraZeneca, Head of MedImmune
Date and Time: Monday, June 6, 2016, 4:00 – 7:00 pm
Location: Clift Hotel, 495 Geary Street San Francisco, CA, 94102
Walk-Ins Accepted?
Yes*
* - Walk-ins will be accepted at the door until event capacity is reached.
Pricing Information
Members
Early bird rate through May 6, 2016: $60
Regular rate through June 2, 2016: $80
Late/walk-in rate beginning June 3, 2016*: $100
Non-Members
Early bird rate through May 6, 2016: $90
Regular rate through June 2, 2016: $110
Late/walk-in rate beginning June 3, 2016*: $130
* - Late/walk-in pricing will be effective at the door on-site.
On-Line Registration Deadline
June 3, 2016
Register at http://www.womeninbio.org/eventdetails.aspx?EventId=28587
Topic Description
In conjunction with the Biotechnology Innovation Organization (BIO) International
Convention, please join us for our signature annual WIB Plenary Event on Monday, June 6,
2016, at the beautiful Clift Hotel. Our panel of esteemed speakers will discuss critical, and
often controversial, issues affecting women in the life sciences industry, identify important
industry trends and how to act on them, and how they created their career paths. This
panel is sure to inspire and motivate both women and men to work together to support the
career development of women!
Date and Time: Monday, June 6, 2016, 4:00 – 6:00 pm
As with all WIB events, our Plenary Event encompasses an inviting and fun environment for
networking as it brings together people from all corners of the life sciences industry, and
spawns new career and business opportunities.
This event is not to be missed so register today!
*****************************************************************
BIO Career Fair, Thursday Afternoon, June 9, 2016
Event: BIO Career Fair
Date and Time: Thursday, June 9, 2016, 2:00 – 7:00 pm
Cost: Free
Details and registration at http://convention.bio.org/careerfair-jobseekers/
BIO is proud to announce the 2016 BIO Career Fair, Thursday June 9 from 2:00 - 7:00 pm.
As an extension of BIO’s online job board—Bio Jobs—the Career Fair will provide an
opportunity for meeting participants and top employers to discuss career opportunities..
The BIO Career Fair (is free) and will allow you access to many of the world’s leading life
science companies. A minimum of a 4-year life science degree OR a community college
20
biotech degree is recommended and military veterans are encouraged to apply. Details at
More information coming soon!
*********************************************************************
qb3, Thursday MidDay, June 9, 2016
Register now for the QB3 Spring 2016 NSF SBIR Bootcamp
UCSF Mission Bay
Two one-hour classes. Location: Genentech Hall N-114, UCSF Mission Bay
First session: Thursday, May 5
Second session: Thursday, June 9
Please note that this workshop will exclusively focus on the specifics of the NSF
application and will not cover the basic information covered in our longer course. For
this reason, we recommend that you sign up for this session if you have previously
attended the QB3 NIH SBIR workshop or have a basic understanding of the SBIR
process.
Our NSF SBIR/STTR workshop will address specific differences between the NSF and
NIH applications to successfully file a well-written SBIR/STTR grant application for
the June 16 NSF SBIR deadline (June 20 for STTRs). The course culminates in a
submission clinic that will ensure your application is correctly filed.
One or more team members from the company should be prepared to attend every
session.
Remember to bring your laptop; these will be working sessions.
Course includes
One 1-hour working session, plus one 1-hour filing clinic
Pre-submission review of specific aims by our course instructors
Session 1 will cover the application process, including registration
Session 2 will cover the upload and submission process
Schedule
Dates Time Location
5/5 (Thurs) 1:00-2:00 PM Room N-114, Genentech Hall
6/9(Thurs) 1:00-2:00 PM Room N-114, Genentech Hall
Instructor: Shauna Farr-Jones, PhD, UCSF/QB3 grant writer
Standard rate for the entire workshop: $150 per company
Discounted rate for UC affiliates, QB3 Startup in a Box members, QB3 Incubator
members, and QB3/CLSA Accelerator members: $50 for entire course per company
Teams registered for the Spring 2016 QB3 NIH SBIR workshop: $0
Have questions about QB3 Spring 2016 NSF SBIR Bootcamp? Contact QB3
*********************************************************************
HPLC, Sunday, June 19, 2016
Topic: “HPLC 2016 - 44th International Symposium and Exhibit on High Performance Liquid
Phase Separations and Related Techniques”
Date and Time: Sunday, June 19, 2016 , 8:30 am
Location: Mariott San Francisco Marquis
The goal of HPLC 2016 is to bring together scientists who use and develop
HPLC, capillary electrophoresis, supercritical fluidic chromatography, microfluidics, and mass
21
spectrometry to exchange ideas, best practices, and
latest developments. The conference program is guided by emerging trends in
separations technology and their impact on science and society.
THREE SESSION TRACKS AT HPLC 2016:
Technology: Better, Faster, Quantitative Separations
Interface to MS: Improving Information Content
BioAnalysis and Applications: Impacting Science and Society
Topics include column and stationary phase technology, interface to mass spectrometry,
microfluidic systems, capillary electrophoresis, LCxLC, QA&QC methods, QbD in separations,
and application to real world problems. A special emphasis in applications will be on
bioanalysis including:
pharmaceuticals, antibody-drug conjugates, antibody characterization, biotechnology,
proteins and proteomics, glycomics, metabolomics and lipidomics, food and nutrition, well-
characterized biologicals, biofuels, environment, and toxicology.
Also Featuring:
Tutorials, Short Courses, User Group Meetings, and Lunch Technical Sessions
For more information, visit: www.hplc2016.org
http://www.hplc2016.org/index.html
Type of Registration: Fees are posted under the "Online Registration" tab located at
www.HPLC2016.org.
Payment must be made by check or credit card payable in US Dollars and drawn on a US
bank (no bank wire transfers).
Registration is not accepted or acknowledged until payment is received.
By submitting this registration, you authorize the HPLC 2016 meeting to share your
information with attendees, etc.
Student Registrants: In order for the student rate to be accepted, must submit proof of
current full-time graduate or undergraduate, not postdoctoral, status at an academic
institution by providing both a copy of your Student I.D and a letter on university stationery
from your department chair along with the department chair contact details and email.
Email the letter and copy of the Student ID to [email protected].
All Oral and Poster Presenters: In order to present, the presenting author of each lecture
and poster must be registered as a conference attendee (not booth staff) and must
complete the registration process by paying online by April 18 to confirm intent to attend
and present at the meeting. If fees are not paid, submissions from that author will be
removed from the program.
Refund Policy: A processing fee of 20% will be collected on cancellations on or before April
1, 2016, after which the fees are non-refundable. Registration is transferable; must contact
Symposium Manager by no later than one week prior to the conference to transfer and
receive confirmation of the transfer of the registration ([email protected] or
telephone 301-668-6001).
HPLC 2016 Symposium/Exhibit Manager
Ms. Janet Cunningham
Barr Enterprises
www.LinkedIn.com/in/BarrEnterprises
phone 301-668-6001
www.HPLC2016.org
***********************************************************
PBSS Workshop, Monday, June 27, 2016
Workshop
Topic: “UHPLC in Biopharmaceutical Analysis: Benefits, Practices, Issues and
Implementation”
22
Speakers: Dr. Michael W. Dong, MWD Consulting
Date and Time: Monday, June 27, 2016, 8:45-12:30
Registration fee (US$): (USD$)Regular: $125; For vendor-show reps: $25; For unemployed
& students: $20; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Agilent
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:6/23/2016 (it will close sooner if the seating cap is reached)
About the Topic
Ultra-high-pressure liquid chromatography (UHPLC) is the new standard HPLC platform
delivering higher performance with small-particle columns used on low-dispersion systems
with pressure limits of 15,000 – 23,000 psi. This intermediate-level 1/2-day training
workshop will provide a critical overview the fundamental concepts, benefits, potential
issues, and best practices of UHPLC in pharmaceutical analysis of small molecule drugs and
recombinant biologics (monoclonal antibodies, mAbs)
Who Should Attend
This workshop is intended for analysts, managers, and researchers wishing to have a
thorough understanding the fundamentals and practices of UHPLC in pharmaceutical
analysis. A basic knowledge of HPLC is assumed and some practical hands-on experience is
highly recommended.
Workshop Agenda
UHPLC 1: Concept and Benefits
1. Overview and perspectives, Glossary, the modern HPLC platform with higher
performance, UHPLC concepts (the need for high pressure, void volume, peak
volume, instrumental bandwidth), UV flow cell design, dwell volume.
2. Benefits and case studies: Very fast separations with good resolution, very high
resolution analysis of complex samples, facilitating rapid method development,
flexibility to customize resolution, a modernized generic method for most drugs, a
greener HPLC platform.
UHPLC 2: Potential Issues, Practices, and implementation
1. Potential issues and how to mitigate (viscous heating, operating nuances,
compatibility to existing methods, injection precision, detector sensitivity vs. mixing
volumes.
2. Method translation (transfer) issues: method portability, method conversion
(translation), “What is method transfer?”, need for partial method validation, case
studies.
3. How to transition from HPLC to UHPLC, end-fittings, system performance tradeoffs,
Myths in UHPLC, references.
Learning Outcomes UHPLC in Biopharmaceutical Analysis
The attendee will learn the benefits, best practices and potential issues of UHPLC in
pharmaceutical analysis including method translation and how to get started in UHPLC.
About the Speakers
Dr. Michael W. Dong is a principal consultant in MWD Consulting focusing on consulting and
training services on HPLC/UHPLC, pharmaceutical analysis and drug quality. He was
formerly Senior Scientist in Analytical Chemistry and Quality Control at Genentech,
Research Director at Synomics Pharma, Research Fellow at Purdue Pharma, and Senior Staff
Scientist at Applied Biosystems / Perkin-Elmer. He holds a Ph.D. in Analytical Chemistry
from the City University of New York, and a certificate in Biotechnology from U. C. Santa
Cruz. He has 100+ publications including a bestselling book on chromatography (Modern
23
HPLC for Practicing Scientists). He is an editorial advisory board member of LCGC magazine
and American Pharmaceutical Review.
*************************************************************
PBSS, Friday MidDay, July 29, 2016
Seminar luncheon
Topic: “CRISPR gene editing platform development for drug discovery and validation”
Speakers: Benjamin Haley, PhD (Genentech)
Organizers:
Date: Friday, July 29, 2016, 11:00-13:30
Registration fee (US$): (USD$);
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:7/27/2016 (it will close sooner if the seating cap is reached)
******************************************************************
Bio2Device Group, Tuesday Evening, August 9, 2016
Topic: TBA
Speaker: Dr. Allison Dupuy, Partner, Simon-Kucher
Date and Time: Tuesday, Aug. 9, 2016, 6:00 pm
Date and Time: Tuesday, Oct. 13, 2015, 6:00pm
Location: Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins (as space permits)
Register at www.Bio2DeviceGroup.org
Speaker Bio
Dr. Allison Dupuy is a Partner in the Life Sciences division of Simon-Kucher & Partners in
San Francisco and leads the company’s life sciences practice on the west coast of the
US. She joined the team in San Francisco in August 2012 after spending 5 years in
Simon-Kucher’s Boston office.
In her work at Simon-Kucher, she focuses on strategic pharmaceutical marketing, value-
to-customer, market entry strategies, pricing and market access strategies, innovative
pricing strategies, product lifecycle strategies, licensing and valuation, market
forecasting and value communication, including global value story development and
implementation. She is a trusted advisor of leading pharmaceutical and biotech
companies across a wide range of therapeutic areas in all major healthcare markets
across the globe.
Dr. Dupuy received her Ph.D. and M.Phil. in Molecular Biophysics and Biochemistry from
Yale University and a B.A. in Physics with honors from Wellesley College where she was
a Goldwater Scholar and a Schiff Fellow.
She is the author and coauthor of several scientific publications and has research
experience in theoretical and experimental physics, biophysics, cell biology, cancer
biology, genomics, proteomics, bioinformatics and biochemistry.
